CB

CDI Bioscience

North America, Wisconsin, United States, Madison

Description

CDI Biosciences develops technologies that increase the yield of bioproducts manufactured in cellular systems.

Investor Profile

CDI Bioscience has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series D rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Therapeutics.

Stage Focus

  • Series D (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does CDI Bioscience frequently co-invest with?

China Development Industrial Bank (CDIB)
Asia, T'ai-pei, Taiwan, Taipei
Co-Investments: 1
Credit Suisse
North America, North Carolina, United States, Morrisville
Co-Investments: 1
Bay City Capital
North America, California, United States, San Francisco
Co-Investments: 1
NM
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1
Manulife Financial
North America, Ontario, Canada, Toronto
Co-Investments: 1
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 1
HealthCap
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 1
Delphi Ventures
North America, California, United States, San Mateo
Co-Investments: 1

What are some of recent deals done by CDI Bioscience?

PTC Therapeutics

South Plainfield, New Jersey, United States

PTC Therapeutics is a biopharmaceutical company that engages in the discovery, development and commercialization of small-molecule drugs.

BiotechnologyHealth CareTherapeutics
Series DSep 19, 2001
Amount Raised: $40,000,000